Healthinvest Partners Ab Lowered Its Pfizer (PFE) Holding; Discovery Capital Management Has Upped Its Bank Amer (BAC) Position

May 25, 2018 - By Marguerite Chambers

Pfizer Inc. (NYSE:PFE) Logo

Healthinvest Partners Ab decreased Pfizer Inc (PFE) stake by 58.58% reported in 2017Q4 SEC filing. Healthinvest Partners Ab sold 106,200 shares as Pfizer Inc (PFE)’s stock declined 3.13%. The Healthinvest Partners Ab holds 75,100 shares with $2.72 million value, down from 181,300 last quarter. Pfizer Inc now has $208.45B valuation. The stock decreased 0.71% or $0.26 during the last trading session, reaching $35.63. About 7.29 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 25, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Discovery Capital Management Llc increased Bank Amer Corp (BAC) stake by 12.35% reported in 2017Q4 SEC filing. Discovery Capital Management Llc acquired 446,844 shares as Bank Amer Corp (BAC)’s stock declined 1.20%. The Discovery Capital Management Llc holds 4.06M shares with $119.97 million value, up from 3.62M last quarter. Bank Amer Corp now has $304.08B valuation. The stock decreased 0.73% or $0.22 during the last trading session, reaching $29.99. About 26.85 million shares traded. Bank of America Corporation (NYSE:BAC) has risen 28.18% since May 25, 2017 and is uptrending. It has outperformed by 16.63% the S&P500.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 79 analyst reports since July 29, 2015 according to SRatingsIntel. SunTrust maintained the shares of PFE in report on Sunday, January 28 with “Hold” rating. Credit Suisse maintained it with “Outperform” rating and $39 target in Monday, May 9 report. On Wednesday, January 31 the stock rating was maintained by Leerink Swann with “Market Perform”. The company was maintained on Wednesday, November 1 by UBS. Morgan Stanley upgraded it to “Overweight” rating and $38 target in Friday, October 2 report. The company was maintained on Friday, April 7 by Morgan Stanley. The company was maintained on Monday, August 14 by Cowen & Co. On Monday, October 16 the stock rating was maintained by SunTrust with “Hold”. Goldman Sachs maintained Pfizer Inc. (NYSE:PFE) rating on Monday, April 18. Goldman Sachs has “Neutral” rating and $35 target. As per Monday, June 20, the company rating was maintained by Jefferies.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “Major Pharma Short Sellers Grow More Selective” on May 25, 2018, also 247Wallst.com with their article: “How Much Pfizer Earnings Depend on a Few Brands” published on May 01, 2018, 247Wallst.com published: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer: Buy This Dip?” published on May 03, 2018 as well as Seekingalpha.com‘s news article titled: “Pfizer Is A Definite Buy For 2018” with publication date: April 30, 2018.

Since December 15, 2017, it had 0 buys, and 13 sales for $17.75 million activity. SUSMAN SALLY sold 33,368 shares worth $1.24M. READ IAN C also sold $4.76M worth of Pfizer Inc. (NYSE:PFE) shares. CORNWELL W DON had sold 1,758 shares worth $64,679. $1.84 million worth of Pfizer Inc. (NYSE:PFE) was sold by LANKLER DOUGLAS M. Dolsten Mikael had sold 13,986 shares worth $501,398. $1.52 million worth of Pfizer Inc. (NYSE:PFE) shares were sold by HILL CHARLES H. 27,323 shares were sold by JOHNSON RADY A, worth $998,666 on Tuesday, March 13.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 EPS, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39 billion for 11.88 P/E if the $0.75 EPS becomes a reality. After $0.77 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. 50,913 are owned by Arcadia Management Corp Mi. Charter Trust reported 1.14% of its portfolio in Pfizer Inc. (NYSE:PFE). Security Natl Co accumulated 1.05% or 89,753 shares. Saturna owns 1.20M shares for 1.33% of their portfolio. Ssi Investment Management Inc owns 0.07% invested in Pfizer Inc. (NYSE:PFE) for 23,584 shares. Schaper Benz And Wise Counsel Inc Wi holds 1.2% of its portfolio in Pfizer Inc. (NYSE:PFE) for 226,950 shares. Moreover, Lvm Capital Mngmt Limited Mi has 0.76% invested in Pfizer Inc. (NYSE:PFE). Associated Banc reported 874,358 shares or 1.71% of all its holdings. Edmp holds 3.1% of its portfolio in Pfizer Inc. (NYSE:PFE) for 99,468 shares. First Amer Financial Bank, a Illinois-based fund reported 178,306 shares. Mraz Amerine And Inc invested 0.12% of its portfolio in Pfizer Inc. (NYSE:PFE). Peconic Partners Ltd Liability Corp holds 0.05% of its portfolio in Pfizer Inc. (NYSE:PFE) for 10,000 shares. Alpha Cubed Invs Ltd Liability Corporation holds 27,272 shares. Capital holds 0.13% or 16.94 million shares. 264,114 are owned by Wilkins Investment Counsel Inc.

Discovery Capital Management Llc decreased Petroleo Brasileiro Sa Petro stake by 3.81M shares to 4.10 million valued at $40.28M in 2017Q4. It also reduced Amazon Com Inc (NASDAQ:AMZN) stake by 100,134 shares and now owns 100,699 shares. Huntington Ingalls Inds Inc (NYSE:HII) was reduced too.

Among 33 analysts covering Bank of America (NYSE:BAC), 22 have Buy rating, 0 Sell and 11 Hold. Therefore 67% are positive. Bank of America had 114 analyst reports since July 21, 2015 according to SRatingsIntel. Macquarie Research upgraded the shares of BAC in report on Tuesday, August 25 to “Underperform” rating. The stock of Bank of America Corporation (NYSE:BAC) has “Mkt Perform” rating given on Tuesday, August 25 by Bernstein. The firm earned “Outperform” rating on Thursday, September 10 by Wells Fargo. The stock of Bank of America Corporation (NYSE:BAC) earned “Buy” rating by Keefe Bruyette & Woods on Tuesday, October 3. The firm earned “Outperform” rating on Monday, August 24 by KBW. The firm has “Hold” rating given on Friday, September 29 by Robert W. Baird. The stock of Bank of America Corporation (NYSE:BAC) has “Buy” rating given on Monday, August 24 by Vetr. The firm has “Buy” rating by Keefe Bruyette & Woods given on Tuesday, December 12. The stock of Bank of America Corporation (NYSE:BAC) earned “Neutral” rating by Guggenheim on Tuesday, November 15. The firm earned “Buy” rating on Friday, January 19 by Sandler O’Neill.

More notable recent Bank of America Corporation (NYSE:BAC) news were published by: Seekingalpha.com which released: “Financial sector the winner today” on May 22, 2018, also Bizjournals.com with their article: “Bank of America rolls out AI assistant Erica to all mobile customers” published on May 21, 2018, Seekingalpha.com published: “Bank Of America: Time To Sell?” on May 08, 2018. More interesting news about Bank of America Corporation (NYSE:BAC) were released by: Investorplace.com and their article: “Friday’s Vital Data: Micron Technology, Inc. (MU), Bank of America Corp (BAC) and Petróleo Brasileiro SA Petrobras …” published on May 25, 2018 as well as Bizjournals.com‘s news article titled: “Gun-control advocates target Bank of America on Remington deal after Santa Fe shooting” with publication date: May 24, 2018.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>